China pharmaceutical business market forecast and investment strategy report, 2013 2017

  • Published on
    17-May-2015

  • View
    174

  • Download
    1

Embed Size (px)

Transcript

  • 1. 2011 China Pharmaceutical Business Market Forecast and Investment Strategy Report, 2013-2017 No comprehensive trend forecast, no gain. (Help you to discover the unsatisfied market need of Pharmaceutical Business, and explicit the development trend and prospect.) 800-8306390 800-8306395 400-0687188 service@qianzhan.com 0755-82940718

2. Pharmaceutical BusinessPreface It is an oversupply economic era and key for corporations to success is that whether they are able to capture the demand before the demand takes shape. The outstanding corporations would prefer to spend great efforts in seeking the current demand, potential need and new requirement of the industry. Competition of nonwoven industry is more and more fierce. In the meantime, merger and capital operation among large pharmaceutical corporations are ever frequent. And the outstanding pharmaceutical corporations in China are placing more importance on the research of the industry market, especially the depth research of industry development environment and customers. Accordingly, many splendid domestic corporations are springing up and become leaders in pharmaceutical business gradually! Basing on the market data of pharmaceutical business http://en.qianzhan.com/report/detail/d5364bdb17284a6b.html , which tracked and collected by Forward in long-term, and applying the international scientific analysis model, this report provides you an overall analysis system in the height of the whole industry comprehensively and accurately. This report mainly analysis the following aspects of Pharmaceutical Business: the development policy environment and demanding environment of Pharmaceutical Business; development status and prospect of Pharmaceutical Business; competition and the development of competitors; development status of Pharmaceutical wholesaling market; development of Pharmaceutical logistics market; development of the terminal of Pharmaceutical Business; and development of Pharmaceutical Business in major cities. Meanwhile, the comprehensive and detailed data about nonwoven industry in current 5 years is contained. In this way, it will help you to maintain the market trend and industry development comprehensively and accurately. The most significant features of this report are perceptiveness and timeliness. It gives a prudent analysis and forecast of pharmaceutical business according to the industry development track and Forwards years of practical experience. In conclusion, it is a significant report to learn about the latest development trend, grab market opportunities, and make correct marketing decision and explicit corporations development trend for all Pharmaceutical wholesalers, retailers, logistics corporations and investors. Besides, it is the first heavyweight report to give a comprehensive and systematic analysis about the significant Pharmaceutical corporations. This report is useful for pharmaceutical wholesalers, retailers, logistics corporations and investors for the following reasons: it will help them to accurately know the latest development trend and timely discover the market gaps, opportunities, growth points and profit points of industrial textile industry; it will assist them to grasp the unmet market demand and development trend prospectively, form the sustainable advantages, avoid the investment risks effectively, consolidate or expand relevant strategic target markets more efficiently, and firmly grasp the competition initiative. Here, we would like to express our sincere gratitude to China Association of Pharmaceutical Commerce, State Information Center, Bureau of Statistics of China, General Administration of Customs, International Information Research Institute, Chinese Academy of International Trade and Economic Cooperation, Tsinghua University Library, Development Research Center of the State Council, for their great support when we conduct this report! Notice: All the market data, especially corporations' ranking data in the report, only for business reference.www.qianzhan.com-2- 3. Pharmaceutical BusinessPlease do not take the data for enterprise publicity. Thank you! Or Forward shall not take any responsibility for any consequences! Special Notes: Neglecting the subtle signals of dramatically changing external environment, and untimely update strategies along with the changing environment will lead to the loss of competition advantages. The successful corporations will keep a scientific analysis upon the external environment before making their significant operational strategies! Forward Business Intelligence sincerely wishes every ambitious corporation can make a significant operational strategy, effectively avoid the industry risks and gain the continuous success! Forward Business Intelligence Co., Ltd. Industry Research Center Research Team of Pharmaceutical Businesswww.qianzhan.com-3- 4. Pharmaceutical BusinessCONTENTS Chapter IDevelopment Background of Pharmaceutical Business 1.1 Researching Methods and Data Sources 1.1.1 Researching Methods 1.1.2 Data Sources 1.2 Definition and Classification of Pharmaceutical Business 1.2.1 Definition of Pharmaceutical Business 1.2.2 Operation Characteristics of Pharmaceutical Business 1.2.3 Types of Pharmaceutical Corporations 1.3 Entry Barriers of Pharmaceutical Business 1.3.1 Barrier of Professional Accreditation 1.3.2 Barrier of Operation Qualification 1.3.3 Barrier of Corporation Scale 1.3.4 Barrier of Brand and Reputation 1.3.5 Barrier of Asset and Strength 1.3.6 Barrier of Marketization 1.3.7 Barrier of Policy 1.4 Policy Environment of Pharmaceutical Business 1.4.1 Supervision Department of Pharmaceutical Business 1.4.2 Management System of Pharmaceutical Business 1.4.3 Development Planning of Pharmaceutical Business 1.5 Economic Environment of Pharmaceutical Business 1.5.1 China GDP Growth 1.5.2 Influence of GDP to Pharmaceutical Business 1.6 Demand Environment of Pharmaceutical Business 1.6.1 Payment Capability of Residents 1.6.2 Aging and Pharmaceutical Business 1.6.3 Urbanization and Pharmaceutical Business Chapter IIDevelopment Status and Prospect of Pharmaceutical Business 2.1 Status and Management Model of Pharmaceutical Supply Chain 2.1.1 Definition of Pharmaceutical Supply Chain 2.1.2 Construction of Pharmaceutical Supply Chain 2.1.3 Development Progress of Pharmaceutical Supply Chain 2.1.4 Management Model of Pharmaceutical Supply Chain (1) Hospital-orient Management Model of Pharmaceutical Supply Chain (2) Supplier-orient Management Model of Pharmaceutical Supply Chain (3) Third-party-Drug-Logistics-orient Management Model of Pharmaceutical Supply Chain (4) Compare of Three Kinds of Management Models of Pharmaceutical Supply Chain 2.2 Business Model and Marketing Strategy of Pharmaceutical Business 2.2.1 Business Models of Pharmaceutical Business (1) Business Model of Retailing Only (2) Business Model of Promotion (3) Business Model of Wholesalingwww.qianzhan.com-4- 5. Pharmaceutical Business(4) Business Model of Agency Service (5) Business Model of Distribution (6) Innovation of Pharmaceutical Business Models 2.2.2 Channels of Pharmaceutical Business 2.2.3 Selection of Marketing Channels of Pharmaceutical Business (1) Influent Factors to Select the Marketing Channel (2) Corporations Sales Team plus Distributors (3) Sole Agency (4) Corporations Sales Team plus Regional Dealers (5) Multi-agency Model 2.3 Development Model and Profit of Pharmaceutical Business 2.3.1 Amount of Pharmaceutical Corporations (1) Corporation Amount and Size (2) Regional Distribution of the Corporations 2.3.2 Market Size of Pharmaceutical Business (1) Total Sales Volume (2) Regional Sales Distribution 2.3.3 Profit of Pharmaceutical Business (1) Traditional Profit Model of Pharmaceutical Business (2) New Profit Model of Pharmaceutical Business (3) Changing of the Profit Level of Pharmaceutical Business (4) Profit Factors of Pharmaceutical Business 2.4 Products Market Size of Pharmaceutical Business 2.4.1 Overview of 7 Major Medicines Market (1) Scale of 7 Major Medicines Market (2) Structure of 7 Major Medicines Market 2.4.2 Analysis of Drug Market (1) Sales of Drugs (2) Pharmacy Scale of the Hospitals (3) Imports and Exports of Drugs 2.4.3 Analysis of Chinese Patent Medicine Market (1) Sales of Chinese Patent Medicine a. Change of Sales Amount b. Change of Sales Proportion c. Regional Distribution (2) Production of Chinese Patent Medicine (3) Imports and Exports of Chinese Patent Medicine 2.4.4 Analysis of Chinese Herbal Medicine Market (1) Sales of Chinese Herbal Medicine a. Change of Sales Amount b. Change of Sales Proportion c. Regional Distribution (2) Imports and Exports of Chinese Herbal Medicine (3) Circulation Status of Chinese Herbal Medicine 2.4.5 Analysis of Medical Apparatus and Instruments Market (1) Sales of Medical Apparatus and Instrumentswww.qianzhan.com-5- 6. Pharmaceutical Businessa. Change of Sales Amount b. Change of Sales Proportion c. Regional Distribution (2) Imports and Exports of Medical Apparatus and Instruments a. Imports Status b. Exports Status (3) Major Medical Apparatus and Instruments 2.4.6 Analysis of Chemical Reagent Market (1) Sales of Chemical Reagent a. Change of Sales Amount b. Change of Sales Proportion (2) Major Chemical Reagent Products 2.4.7 Analysis of Glassware Instrument Market 2.4.8 Market of other Products 2.5 Prospect Forecast of the Development of Pharmaceutical Business 2.5.1 Driving Factors to the Development of Pharmaceutical Business 2.5.2 Limited Factors to the Development of Pharmaceutical Business 2.5.3 Development Prospect of Pharmaceutical Business Chapter IIICompetition of Significant Pharmaceutical Corporations 3.1 Competitive Structure of Pharmaceutical Corporations 3.1.1 Scale and Structure of Pharmaceutical Corporations 3.1.2 Concentration Ratio of Pharmaceutical Corporations (1) Upgrading Bottom Line of Top 100 Corporations (2) Market Concentration Ratio of Top 3 Pharmaceutical Corporations (3) Concentration Ratio Forecast of Pharmaceutical Business 3.2 Financing Strategy of Pharmaceutical Corporations 3.2.1 Financing Model of Pharmaceutical Corporations 3.2.2 Financing Channel of Public Pharmaceutical Company 3.2.3 Financing Cases of Public Pharmaceutical Company 3.2.4 Financing Strategy of Public Pharmaceutical Company 3.3 Analysis of Major Pharmaceutical Corporations 3.3.1 Analysis of Sinopharm Group Co., Ltd. (1) Development Briefing of the Company (2) Major Business and Products of the Company (3) Major Customers and Suppliers of the Company (4) Operation Status of the Company a. Major Economic Indexes b. Profitability of the Company c. Operation Capability of the Company d. Debt-paying Capability of the Company e. Development Capability of the Company (5) Operation Advantages and Disadvantages of the Company (6) Logistics System Construction of the Company (7) Investment and Development Trend of the Companywww.qianzhan.com-6- 7. Pharmaceutical Business(8) Subsidiary of Sinopharm Group Co., Ltd. a. Development Briefing b. Category of the Retailing Products c. Operation Status d. Distribution of Retailing Network 3.3.2 Analysis of China National Accord Medicines Corporation Ltd. (Analysis items are identical to the first company) 3.3.3 Analysis of China National Medicines Corporation Ltd. (Analysis items are identical to the first company) 3.3.4 Analysis of Shanghai Pharmaceuticals Holding Co., Ltd. (Analysis items are identical to the first company) 3.3.5 Analysis of Nanjing Pharmaceutical Co., Ltd. (Analysis items are identical to the first company) 3.3.6 Analysis of Guangzhou Pharmaceutical Co., Ltd. (Analysis items are identical to the first company) 3.3.7 Analysis of Anhui Huayuan Pharmaceutical Co., Ltd. (Analysis items are identical to the first company) 3.3.8 Analysis of Beijing Pharmaceutical CO., LTD. (Analysis items are identical to the first company) 3.3.9 Analysis of Jointown Pharmaceutical Group Co., Ltd. (Analysis items are identical to the first company) 3.3.10Analysis of Tianjin Pharmaceutical Holdings Ltd.(Analysis items are identical to the first company) 3.3.11Analysis of Huadong Medicine Co., Ltd.(Analysis items are identical to the first company) 3.3.12Analysis of Zhejiang Int'l Group Co., Ltd.(Analysis items are identical to the first company) 3.3.13Analysis of Harbin Pharmaceutical Group Co., Ltd.(Analysis items are identical to the first company) 3.3.14Analysis of China Meheco Co., Ltd.(Analysis items are identical to the first company) 3.3.15Analysis of Shijiazhuang Lerentang Medical Group Co., Ltd.(Analysis items are identical to the first company) 3.3.16Analysis of Yunnan Baiyao Group Co., Ltd.(Analysis items are identical to the first company) 3.3.17Analysis of Joincare Pharmaceutical Group Industry Co.,Ltd.(Analysis items are identical to the first company) 3.3.18Analysis of CHONGQING TONG JUN GE CO., LTD.(Analysis items are identical to the first company) 3.3.19Analysis of Chongqing Taiji Industry (Group) Co., Ltd.(Analysis items are identical to the first company) 3.3.20Analysis of Shandong Neptunus Group Co., Ltd.(Analysis items are identical to the first company) 3.3.21Analysis of Northeast Pharmaceutical Group Co., Ltd.(Analysis items are identical to the first company) 3.3.22Analysis of Hebei Dongsheg Yinghua Pharmaceutical Co., Ltd.www.qianzhan.com-7- 8. Pharmaceutical Business(Analysis items are identical to the first company) 3.3.23Analysis of TASLY PHARMACEUTICAL GROUP CO., LTD.(Analysis items are identical to the first company) 3.3.24Analysis of Beijing Tongrentang Co.,Ltd.(Analysis items are identical to the first company) 3.3.25Analysis of Shandong Realcan Pharmaceutical Co., Ltd.(Analysis items are identical to the first company) 3.3.26Analysis of Cachet Pharmaceutical Co., Ltd.(Analysis items are identical to the first company) 3.3.27Analysis of China Nepstar Chain Drugstore Ltd.(Analysis items are identical to the first company) 3.3.28Analysis of Lao Bai Xing Big Drugstore Chain Co., Ltd.(Analysis items are identical to the first company) 3.3.29Analysis of Guangdong DA SHEN LIN Chain Drugstore Ltd.(Analysis items are identical to the first company) Chapter IVStatus and Prospect of Pharmaceutical Wholesaling Market 4.1 Operation Status of Foreign Pharmaceutical Wholesales 4.1.1 Functions of Pharmaceutical Wholesalers 4.1.2 Analysis of Pharmaceutical Wholesalers in America (1) Pharmaceutical Supply Chain in America (2) Operation Environment of Pharmaceutical Wholesalers in America (3) Operation Characteristics of Pharmaceutical Wholesalers in America (4) Analysis of McKesson 4.1.3 Analysis of Pharmaceutical Wholesalers in Japan (1) Pharmaceutical Supply Chain in Japan (2) Operation Environment of Pharmaceutical Wholesalers in Japan (3) Operation Characteristics of Pharmaceutical Wholesalers in Japan (4) Analysis of TOHO Medicine Limited 4.2 Status of Pharmaceutical Wholesaling Market in China 4.2.1 Scale of Pharmaceutical Wholesaling Mar...